Literature DB >> 4059071

The value of early repair for total anomalous pulmonary venous drainage.

A C Galloway, D N Campbell, D R Clarke.   

Abstract

A total of 20 children with total anomalous pulmonary venous drainage (TAPVD) underwent complete repair within the past six years. The drainage was supracardiac in 11, infracardiac in seven, and into the coronary sinus in two. At repair mean age was nine weeks, and weight was 3.7 km. Operative technique in extracardiac types included complete mobilization of the common vein with division of anomalous channel when possible. The incision in the confluent vein was extended into the lobar veins when necessary to permit extensive incorporation of this structure into the posterior wall of the left atrium and resulted in a nonobstructing stellate-type anastomosis. Operative mortality was 10% (2 of 20). Deaths occurred only in the group of infants in whom severe obstruction to pulmonary venous return required emergency operation, and one of these patients has persistent neurologic deficit. Late cardiac catheterization has been performed in 11 of 18 survivors. Nine had no or only minor abnormalities and two required reoperation. There have been no late deaths with follow-up of 2-8 years (mean = 4 years). Currently, all of the survivors are without cardiac symptoms and only one requires cardiac medication. Our experience identifies pulmonary venous obstruction with critical symptoms as the major operative risk factor in patients with TAPVD. With early operation prior to onset of critical symptoms, mortality is low and functional results are excellent.

Entities:  

Mesh:

Year:  1985        PMID: 4059071     DOI: 10.1007/BF02282742

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  27 in total

1.  Profound hypothermia in cardiac surgery: report of three cases.

Authors:  C E DREW; I M ANDERSON
Journal:  Lancet       Date:  1959-04-11       Impact factor: 79.321

2.  Open intracardiac operations: use of circulatory arrest during hypothermia induced by blood cooling.

Authors:  J W KIRKLIN; B DAWSON; R A DEVLOO; R A THEYE
Journal:  Ann Surg       Date:  1961-11       Impact factor: 12.969

3.  Correction of total anomalous pulmonary venous drainage in infancy.

Authors:  I M Breckenridge; M De Leval; J Stark; D J Waterston
Journal:  J Thorac Cardiovasc Surg       Date:  1973-09       Impact factor: 5.209

4.  Balloon atrial septostomy for total anomalous pulmonary venous return.

Authors:  C E Mullins; G M el-Said; W H Neches; R L Williams; T A Vargo; M R Nihill; D G McNamara
Journal:  Br Heart J       Date:  1973-07

5.  Management of total anomalous pulmonary venous return.

Authors:  G el-Said; C E Mullins; D G McNamara
Journal:  Circulation       Date:  1972-06       Impact factor: 29.690

6.  Cardiac function in total anomalous pulmonary venous return before and after surgery.

Authors:  R Mathew; O G Thilenius; R L Replogle; R A Arcilla
Journal:  Circulation       Date:  1977-02       Impact factor: 29.690

7.  Total anomalous pulmonary venous drainage in infancy.

Authors:  D R Clarke; J Stark; M De Leval; J R Pincott; J F Taylor
Journal:  Br Heart J       Date:  1977-04

8.  Duration of circulatory arrest does influence the psychological development of children after cardiac operation in early life.

Authors:  F C Wells; S Coghill; H L Caplan; C Lincoln
Journal:  J Thorac Cardiovasc Surg       Date:  1983-12       Impact factor: 5.209

9.  Concepts and practices in surgery for total anomalous pulmonary venous connection.

Authors:  N M Katz; J W Kirklin; A D Pacifico
Journal:  Ann Thorac Surg       Date:  1978-05       Impact factor: 4.330

10.  Pre and postoperative ventricular function in infants and children with right ventricular volume overload.

Authors:  M Nakazawa; J M Jarmakani; M T Gyepes; J V Prochazka; S M Yabek; R A Marks
Journal:  Circulation       Date:  1977-03       Impact factor: 29.690

View more
  1 in total

1.  Obstructed total anomalous pulmonary venous connection.

Authors:  J K Wang; H C Lue; M H Wu; M L Young; F F Wu; J M Wu
Journal:  Pediatr Cardiol       Date:  1993-01       Impact factor: 1.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.